It's gone through! Obama signs Sunscreen Innovation Act

By Michelle Yeomans contact

- Last updated on GMT

It's gone through! Obama signs Sunscreen Innovation Act

Related tags: Sunscreen innovation act, Sunscreen

President Obama has signed the Sunscreen Innovation Act into law, which modifies the FDA review and approval process of over-the-counter sunscreen ingredients.

Following on from senate approval for the Sunscreen Innovation act in October, the bill has finally been signed by the President which aims to streamline the sunscreen approval regulatory process, enabling the FDA to approve new ingredients far more efficiently.

Until now the system for the approval of OTC sunscreens has been long-winded and bureaucratic, demanding ingredient providers supply a significant amount of paperwork.

The Act will ultimately help to provide Americans with access to the latest sunscreen ingredients, some of which have been widely available for 15 years in Europe, Asia and Latin America. 

That process takes around a year to secure approval but because of the lengthy process a considerable backlog has built up, which means approval is now taking much longer than that.

What does this now mean for sunscreen makers?

The current regulatory system for sunscreens was established in 2002, promulgating a two-part process which classifies such active ingredients under the OTC drug monograph system.

The backlog of ingredients includes eight that have been waiting approval for years - amiloxate, 10%; bemotrizinol, 10%; bisoctrizole, 10%; *diethylhexyl butamido triazone, 3%; drometrizole trisiloxane, 15%; ecamsule, 10%; enzacamene, 4%; *octyl triazone, 5%. 

“If the Sunscreen Innovation Act is passed, we will hopefully see these pending requests either granted or denied within the next year and a half. That, as you can imagine, is beneficial to all as more options for active ingredients will be available for use,”​ regulation law expert Angela Diesch told CosmeticsDesign-Europe.com, back in September.

Founding member of the PASS Coalition, L’Oréal USA had also released a statement prior to passing of the Bill.

“L’Oréal commends the House of Representatives for its unanimous passage of the Senate version of the Sunscreen Innovation Act (S.2141), which will provide American consumers greater access and choice when it comes to the latest and effective sunscreen products available," ​said chief communications officer, Kristina Schake.

Related topics: Regulation & Safety, Skin Care

Related news

Show more

Related products

show more

Tagra WS SA50TM Water-Soluble Salicylic Acid

Tagra WS SA50TM Water-Soluble Salicylic Acid

Tagra Biotechnologies | 04-May-2021 | Product Presentation

Watch Tagra’s Water Soluble Salicylic Acid WS SA50™ video and discover a new generation form of Salicylic Acid. Thanks to its water-solubility, WS SA50™...

Sequoia cells to limit male skin ageing

Sequoia cells to limit male skin ageing

Naolys | 30-Apr-2021 | Product Brochure

During SCS Formulate, Naolys, the specialist in plant cell culture, presented their new product dedicated to male skin: Sequoia plant cells that protect...

Regenerative Beauty

Regenerative Beauty

Symrise | Webinar

The past year has ignited a renewed focus and appreciation of nature and the earth, as many consumers are reevaluating their habits to be more conscious...

Register for free

Related suppliers

Follow us

Products

View more

Webinars